U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C8H15NO3
Molecular Weight 173.2096
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SCH-50911 FREE BASE

SMILES

CC1(C)CO[C@@H](CC(O)=O)CN1

InChI

InChIKey=SEYCKMQSPUVYEF-LURJTMIESA-N
InChI=1S/C8H15NO3/c1-8(2)5-12-6(4-9-8)3-7(10)11/h6,9H,3-5H2,1-2H3,(H,10,11)/t6-/m0/s1

HIDE SMILES / InChI

Molecular Formula C8H15NO3
Molecular Weight 173.2096
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
1100.0 nM [IC50]
PubMed

PubMed

TitleDatePubMed
Gamma-aminobutyric acidB (GABAB)-receptor mediation of different in vivo effects of gamma-butyrolactone.
2008-02
Effects of GABA(B) receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced self-administration and drug discrimination.
2007-11-28
Effects of GABA(B) receptor agents on cocaine priming, discrete contextual cue and food induced relapses.
2007-10-01
Resuscitative treatments on 1,4-butanediol mortality in mice.
2006-02
Up-regulation of GABA(B) receptors by chronic administration of the GABA(B) receptor antagonist SCH 50,911.
2005-05-16
Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: evidence for GABA(B) receptor-mediated effects.
2005
Protection by the GABAB receptor antagonist, SCH 50911, of gamma-hydroxybutyric acid-induced mortality in mice.
2004-10-25
3-Morpholinylsydnonimine inhibits glutamatergic transmission in rat rostral ventrolateral medulla via peroxynitrite formation and adenosine release.
2004-09
Pharmacological characterisation of a cell line expressing GABA B1b and GABA B2 receptor subunits.
2003-04-01
Proconvulsive effect of the GABA(B) receptor antagonist, SCH 50911, in rats undergoing ethanol withdrawal syndrome.
2002-06-12
Central effects of 1,4-butanediol are mediated by GABA(B) receptors via its conversion into gamma-hydroxybutyric acid.
2002-04-26
GABA(B) receptor inhibition causes locomotor stimulation in mice.
2001-12-14
gamma-Hydroxybutyric acid and baclofen decrease extracellular acetylcholine levels in the hippocampus via GABA(B) receptors.
2001-11-02
Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid.
2001-10-12
Modification of d-amphetamine-induced responses by baclofen in rats.
2001-01
The human GABA(B1b) and GABA(B2) heterodimeric recombinant receptor shows low sensitivity to phaclofen and saclofen.
2000-11
Characterization of the antiabsence effects of SCH 50911, a GABA-B receptor antagonist, in the lethargic mouse, gamma-hydroxybutyrate, and pentylenetetrazole models.
1995-09
The pharmacology of SCH 50911: a novel, orally-active GABA-beta receptor antagonist.
1995-09
Substance Class Chemical
Created
by admin
on Mon Mar 31 21:08:25 GMT 2025
Edited
by admin
on Mon Mar 31 21:08:25 GMT 2025
Record UNII
13OB0KEU61
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SCH 50911 FREE BASE
Preferred Name English
SCH-50911 FREE BASE
Common Name English
2-MORPHOLINEACETIC ACID, 5,5-DIMETHYL-, (2S)-
Common Name English
Code System Code Type Description
PUBCHEM
5311429
Created by admin on Mon Mar 31 21:08:25 GMT 2025 , Edited by admin on Mon Mar 31 21:08:25 GMT 2025
PRIMARY
CAS
733717-87-8
Created by admin on Mon Mar 31 21:08:25 GMT 2025 , Edited by admin on Mon Mar 31 21:08:25 GMT 2025
PRIMARY
EPA CompTox
DTXSID701336120
Created by admin on Mon Mar 31 21:08:25 GMT 2025 , Edited by admin on Mon Mar 31 21:08:25 GMT 2025
PRIMARY
FDA UNII
13OB0KEU61
Created by admin on Mon Mar 31 21:08:25 GMT 2025 , Edited by admin on Mon Mar 31 21:08:25 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
SALT/SOLVATE -> PARENT